• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insurance Stocks Moving In Monday's Intraday Session

    2/12/24 12:40:10 PM ET
    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Property-Casualty Insurers
    Finance
    Property-Casualty Insurers
    Finance
    Get the next $FGF alert in real time by email

    According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

    Gainers

    • Hippo Holdings (NYSE:HIPO) stock rose 11.54% to $10.92 during Monday's regular session. As of 12:40 EST, this security is trading at a volume of 97.0K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $233.8 million.
    • Trupanion (NASDAQ:TRUP) shares increased by 6.75% to $32.73. As of 12:40 EST, Trupanion's stock is trading at a volume of 194.3K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion.
    • Huize Holding (NASDAQ:HUIZ) stock increased by 6.15% to $0.69. Huize Holding's stock is trading at a volume of 3.7K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $34.0 million.
    • James River Gr Hldgs (NASDAQ:JRVR) stock rose 5.9% to $10.05. As of 12:40 EST, this security is trading at a volume of 136.2K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $359.8 million.
    • SelectQuote (NYSE:SLQT) stock rose 5.59% to $1.51. Trading volume for this security as of 12:40 EST is 809.6K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $251.5 million. As per the press release, Q2 earnings came out 3 days ago.
    • Greenlight Capital Re (NASDAQ:GLRE) shares moved upwards by 3.97% to $12.03. The current volume of 74.0K shares is 0% of Greenlight Capital Re's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $408.8 million.

    Losers

    • FG Finl Gr (NASDAQ:FGF) stock declined by 8.92% to $1.23 during Monday's regular session. The current volume of 36.2K shares is 0% of FG Finl Gr's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $15.3 million.
    • Tian Ruixiang Holdings (NASDAQ:TIRX) shares fell 7.56% to $0.58. The current volume of 29.4K shares is 0% of Tian Ruixiang Holdings's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $1.9 million.
    • Marpai (NASDAQ:MRAI) stock declined by 3.91% to $1.23. As of 12:40 EST, Marpai's stock is trading at a volume of 29.1K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $11.3 million.
    • Crawford (NYSE:CRD) stock declined by 2.91% to $12.38. Trading volume for this security as of 12:40 EST is 19.5K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at 605219326.
    • Oscar Health (NYSE:OSCR) shares declined by 2.04% to $17.32. As of 12:40 EST, this security is trading at a volume of 1.9 million shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 billion. As per the press release, Q4 earnings came out 3 days ago.
    • Reliance Global Group (NASDAQ:RELI) shares declined by 1.59% to $0.48. As of 12:40 EST, this security is trading at a volume of 31.8K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $FGF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FGF
    $GLRE
    $HIPO
    $HUIZ

    CompanyDatePrice TargetRatingAnalyst
    Oscar Health Inc.
    $OSCR
    2/12/2026$18.00Mkt Perform → Outperform
    Raymond James
    Oscar Health Inc.
    $OSCR
    1/9/2026$17.00Sell → Neutral
    UBS
    Oscar Health Inc.
    $OSCR
    1/5/2026$18.00Underweight → Equal Weight
    Barclays
    James River Group Holdings Inc.
    $JRVR
    12/16/2025$7.00Buy → Neutral
    Compass Point
    Oscar Health Inc.
    $OSCR
    12/11/2025$17.00Equal-Weight
    Stephens
    Oscar Health Inc.
    $OSCR
    11/26/2025$25.00Neutral → Overweight
    Piper Sandler
    Oscar Health Inc.
    $OSCR
    10/14/2025$17.00Neutral
    Goldman
    Trupanion Inc.
    $TRUP
    8/13/2025$47.00Neutral
    Cantor Fitzgerald
    More analyst ratings

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trupanion Reports Fourth Quarter & Full Year 2025 Results

    SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while increasing subscription revenue and reinvesting record profits to drive four straight quarters of higher retention and accelerating gross pet adds. We're poised to advance confidently into our n

    2/12/26 4:05:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    TIAN RUIXIANG Unveils unprecedented Asia-Pacific AI Healthcare Revolution: Strategic Partnership & Acquisition of Singapore's Top 3 Medical Leaders to Dominate AI-Driven Diagnostics Across Southeast Asia

    Beijing/Singapore, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited ("Tianruixiang" or the "Company") (NASDAQ:TIRX), a global trailblazer in AI-powered insurance innovation, today announced a landmark expansion of its transformative ecosystem, cementing its position as the undisputed leader in AI-driven healthcare across Southeast Asia and the Asia-Pacific. Building on its historic AI initiative with top-tier global insurance firms, TIRX has entered into strategic partnership and acquisition discussions with Singapore's top three medical technology leaders, a move set to redefine the future of insurance-clinic integration and precision diagnostics in the region. The propo

    2/12/26 9:32:41 AM ET
    $TIRX
    Specialty Insurers
    Finance

    Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025

    Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the

    2/10/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/12/26 4:30:05 PM ET
    $TIRX
    Specialty Insurers
    Finance

    Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TRUPANION, INC. (0001371285) (Filer)

    2/12/26 4:01:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Hippo Holdings Inc.

    SCHEDULE 13G/A - Hippo Holdings Inc. (0001828105) (Subject)

    2/12/26 2:58:46 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oscar Health upgraded by Raymond James with a new price target

    Raymond James upgraded Oscar Health from Mkt Perform to Outperform and set a new price target of $18.00

    2/12/26 7:19:33 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health upgraded by UBS with a new price target

    UBS upgraded Oscar Health from Sell to Neutral and set a new price target of $17.00

    1/9/26 8:33:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health upgraded by Barclays with a new price target

    Barclays upgraded Oscar Health from Underweight to Equal Weight and set a new price target of $18.00

    1/5/26 8:36:06 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mccathron Richard sold $145,700 worth of shares (5,000 units at $29.14), decreasing direct ownership by 1% to 442,704 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/11/26 4:52:46 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Chief Operating Officer Gallagher John R sold $13,618 worth of shares (430 units at $31.67), decreasing direct ownership by 1% to 31,861 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    1/29/26 6:57:35 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Chief Executive Officer Mccathron Richard sold $157,600 worth of shares (5,000 units at $31.52), decreasing direct ownership by 1% to 447,704 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    1/13/26 5:47:52 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Foley Ursuline F bought $64,591 worth of ORDINARY SHARES (5,000 units at $12.92), increasing direct ownership by 10% to 54,100 units (SEC Form 4)

    4 - GREENLIGHT CAPITAL RE, LTD. (0001385613) (Issuer)

    11/21/25 11:30:05 AM ET
    $GLRE
    Property-Casualty Insurers
    Finance

    Director Platt Joseph P Jr bought $64,863 worth of ORDINARY SHARES (5,000 units at $12.97) (SEC Form 4)

    4 - GREENLIGHT CAPITAL RE, LTD. (0001385613) (Issuer)

    11/19/25 3:08:45 PM ET
    $GLRE
    Property-Casualty Insurers
    Finance

    Director Eitan Yaron bought $100,000 worth of shares (100,000 units at $1.00), increasing direct ownership by 10% to 1,089,073 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    11/12/25 6:50:17 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Leadership Updates

    Live Leadership Updates

    View All

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Crawford & Company® Announces New Operating Divisions

    Appoints Michael Hoberman CEO of U.S. Operations Crawford & Company® (NYSE:CRD) has announced a new global operating structure designed to accelerate its client-centric strategy to deliver an integrated service model, strengthen collaboration across geographies and enhance the company's ability to deliver unmatched service to clients worldwide. Effective January 1, 2026, Crawford will operate under two divisions – U.S. Operations and International Operations – reflecting a simplified, more client-centric model built for speed, accountability and market responsiveness. Under the new structure, Mike Hoberman has been promoted to CEO of U.S. Operations, reporting to interim Crawford Pres

    1/21/26 4:15:00 PM ET
    $CRD

    Crawford & Company® Announces Leadership Transition; Appoints W. Bruce Swain, Jr. Interim President & CEO

    Rohit Verma has announced intention to step down effective December 31, 2025 Crawford & Company® (NYSE:CRD) is pleased to announce that W. Bruce Swain, Jr., will assume the role of interim president & chief executive officer following Rohit Verma's decision to step down effective December 31, 2025, to pursue a new opportunity. Currently serving as chief financial officer, Swain will assume the role of interim president & CEO and member of the Crawford Board of Directors, on January 1, 2026. With more than three decades at Crawford, Swain has been instrumental in shaping the company's financial strategy and global operations. His deep understanding of Crawford's business, combined with e

    11/21/25 8:15:00 AM ET
    $CRD

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Reliance Global Group Inc.

    SC 13G/A - Reliance Global Group, Inc. (0001812727) (Subject)

    11/14/24 4:26:59 PM ET
    $RELI
    Specialty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by Oscar Health Inc.

    SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)

    11/14/24 4:07:27 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $FGF
    $GLRE
    $HIPO
    $HUIZ
    Financials

    Live finance-specific insights

    View All

    Trupanion Reports Fourth Quarter & Full Year 2025 Results

    SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while increasing subscription revenue and reinvesting record profits to drive four straight quarters of higher retention and accelerating gross pet adds. We're poised to advance confidently into our n

    2/12/26 4:05:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025

    Achieves Record Membership of ~3.4 Million and Provides Full-Year 2026 Outlook Including More Than $18 Billion in Revenue Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Mark Bertolini, CEO of Oscar Health. "Our new suite of affordable products, agentic AI features, and exceptional member experience drove record-high membership – positioning us to achieve significantly improved financial performance in 2026. Oscar's growth demonstrates consumers vote where the

    2/10/26 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Crawford & Company Board Declares Quarterly Dividends

    On February 5, 2026, at its regular quarterly meeting, the Board of Directors of Crawford & Company® (NYSE:CRD) approved a quarterly dividend of $0.075 per share on both Class A and Class B Common Stock. The dividend is payable on March 6, 2026, to shareholders of record as of the close of business on February 23, 2026. About Crawford® Based in Atlanta, Crawford & Company (NYSE:CRD) is a leading global provider of claims management and outsourcing solutions to insurance companies and self‐insured entities with an expansive network serving clients in more than 70 countries. The Company's two classes of stock are substantially identical, except with respect to voting rights for the Class

    2/6/26 10:30:00 AM ET
    $CRD